Susanna Fletcher Greer, Chief Scientific Officer at the V Foundation, shared a post by the V Foundation on LinkedIn, adding:
”I’m so energized by this partnership between the the V Foundation and Cancer Vaccine Coalition, a bold commitment to push therapeutic vaccine science forward.
With this collaboration, we are investing in clinical trials that train the immune system to recognize and eliminate cancer cells after diagnosis, aiming to reduce recurrence, not just prevent disease.
Deep admiration to Kristen Dahlgren for channeling her experience into catalytic action. Her leadership is helping ensure that the most promising vaccine science gets translated into real opportunity for patients and families.”
Quoting The V Foundation‘s post:
”This Breast Cancer Awareness Month, we’re proud to highlight our partnership with Cancer Vaccine Coalition.
Together, we’re accelerating the future of breast cancer treatment through bold, innovative research — and bringing real hope to patients.
To date, the V Foundation has granted nearly $35 million to breast cancer research.
More posts featuring Susanna Fletcher Greer.